These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3138406)

  • 21. Midazolam and triazolam: hypnotic action and residual effects after a single bedtime dose.
    Borbély AA; Loepfe M; Mattmann P; Tobler I
    Arzneimittelforschung; 1983; 33(10):1500-2. PubMed ID: 6140018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of midazolam on memory.
    Borbély AA; Schläpfer B; Trachsel L
    Arzneimittelforschung; 1988 Jun; 38(6):824-7. PubMed ID: 3178924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergism by caffeine and by cocaine of the motor control deficit produced by midazolam.
    Falk JL; Lau CE
    Pharmacol Biochem Behav; 1991 Jun; 39(2):525-9. PubMed ID: 1946593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of sedation in quail induced by use of midazolam and reversed by use of flumazenil.
    Day TK; Roge CK
    J Am Vet Med Assoc; 1996 Sep; 209(5):969-71. PubMed ID: 8790552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Midazolam attenuates the antinociception induced by d-serine or morphine at the supraspinal level in rats.
    Ito K; Yoshikawa M; Maeda M; Jin XL; Takahashi S; Matsuda M; Tamaki R; Kobayashi H; Suzuki T; Hashimoto A
    Eur J Pharmacol; 2008 May; 586(1-3):139-44. PubMed ID: 18384770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous flumazenil following acute and repeated exposure to lorazepam in healthy volunteers: antagonism and precipitated withdrawal.
    Griffiths RR; Evans SM; Guarino JJ; Roache JD; Furman WR; Liebson I; Schwam EM
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1163-74. PubMed ID: 8510001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zolpidem self-injection with concurrent physical dependence under conditions of long-term continuous availability in baboons.
    Weerts EM; Griffiths RR
    Behav Pharmacol; 1998 May; 9(3):285-97. PubMed ID: 9832941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physical dependence in baboons chronically treated with low and high doses of diazepam.
    Kaminski BJ; Sannerud CA; Weerts EM; Lamb RJ; Griffiths RR
    Behav Pharmacol; 2003 Jul; 14(4):331-42. PubMed ID: 12838039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discriminative stimulus effects of positive GABAA modulators and other anxiolytics, sedatives, and anticonvulsants in untreated and diazepam-treated monkeys.
    McMahon LR; France CP
    J Pharmacol Exp Ther; 2003 Jan; 304(1):109-20. PubMed ID: 12490581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of flumazenil on ethanol withdrawal syndrome in rats.
    Uzbay IT; Akarsu ES; Kayaalp SO
    Arzneimittelforschung; 1995 Feb; 45(2):120-4. PubMed ID: 7710430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conflicting evidence regarding the efficacy of ondansetron in benzodiazepine withdrawal.
    Prather PL; Rezazadeh SM; Lane JD; Rowan GA; Hooper ML; Lytle DA; Emmett-Oglesby MW; Lal H
    J Pharmacol Exp Ther; 1993 Feb; 264(2):622-30. PubMed ID: 8094750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relation between discriminative and reinforcing effects of midazolam, pentobarbital, chlordiazepoxide, zolpidem, and imidazenil in baboons.
    Ator NA
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):477-87. PubMed ID: 12373448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of behavioral effects of bretazenil by flumazenil and ZK 93,426 in pigeons.
    Witkin JM; Acri JB; Gleeson S; Barrett JE
    Pharmacol Biochem Behav; 1997 Jan; 56(1):1-7. PubMed ID: 8981602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioral and biochemical characterization of benzodiazepine receptor partial agonists in pigeons.
    Witkin JM; Acri JB; Wong G; Gleeson S; Barrett JE
    J Pharmacol Exp Ther; 1996 Apr; 277(1):87-96. PubMed ID: 8613971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis.
    Schulteis G; Markou A; Gold LH; Stinus L; Koob GF
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1391-8. PubMed ID: 7996451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastrointestinal motor alterations induced by precipitated benzodiazepine withdrawal in rats.
    Martinez J; Fargeas MJ; Bueno L
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1067-72. PubMed ID: 1312156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects on night-time motor activity and performance in the morning after midazolam intake during the night.
    Tobler I; Dijk DJ; Jaggi K; Borbély AA
    Arzneimittelforschung; 1991 Jun; 41(6):581-3. PubMed ID: 1930343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral tolerance to the force differentiation effects of diazepam and midazolam in rats.
    Bowen SE; Fowler SC; Stanford JA; Kallman MJ
    Psychopharmacology (Berl); 2000 Mar; 148(4):327-35. PubMed ID: 10928303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute tolerance and reversal of the motor control effects of midazolam.
    Coldwell SE; Kaufman E; Milgrom P; Kharasch ED; Chen P; Mautz D; Ramsay DS
    Pharmacol Biochem Behav; 1998 Feb; 59(2):537-45. PubMed ID: 9477005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.